{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:07:58Z","timestamp":1787789278145,"version":"build-2784847793"},"reference-count":184,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s11427-024-2648-0","type":"journal-article","created":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T21:01:23Z","timestamp":1733691683000},"page":"974-993","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Regulation and application of m6A modification in tumor immunity"],"prefix":"10.1007","volume":"68","author":[{"given":"Qunli","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaguang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"key":"2648_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.trsl.2023.04.005","volume":"259","author":"X An","year":"2023","unstructured":"An, X., Wu, W., Yang, L., Dong, J., Liu, B., Guo, J., Chen, J., Guo, B., Cao, W., and Jiang, Q. (2023). ZBTB7C m6A modification incurred by METTL3 aberration promotes osteosarcoma progression. Transl Res 259, 62\u201371.","journal-title":"Transl Res"},{"key":"2648_CR2","doi-asserted-by":"publisher","first-page":"5157","DOI":"10.1093\/nar\/gkaa227","volume":"48","author":"T Aoyama","year":"2020","unstructured":"Aoyama, T., Yamashita, S., and Tomita, K. (2020). Mechanistic insights into m6A modification of U6 snRNA by human METTL16. Nucleic Acids Res 48, 5157\u20135168.","journal-title":"Nucleic Acids Res"},{"key":"2648_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","volume":"16","author":"S Bagchi","year":"2021","unstructured":"Bagchi, S., Yuan, R., and Engleman, E.G. (2021). Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance. Annu Rev Pathol Mech Dis 16, 223\u2013249.","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"2648_CR4","doi-asserted-by":"publisher","first-page":"e003663","DOI":"10.1136\/jitc-2021-003663","volume":"10","author":"X Bai","year":"2022","unstructured":"Bai, X., Wong, C.C., Pan, Y., Chen, H., Liu, W., Zhai, J., Kang, W., Shi, Y., Yamamoto, M., Tsukamoto, T., et al. (2022). Loss of YTHDF1 in gastric tumors restores sensitivity to antitumor immunity by recruiting mature dendritic cells. J Immunother Cancer 10, e003663.","journal-title":"J Immunother Cancer"},{"key":"2648_CR5","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1136\/gutjnl-2022-328845","volume":"72","author":"Y Bao","year":"2023","unstructured":"Bao, Y., Zhai, J., Chen, H., Wong, C.C., Liang, C., Ding, Y., Huang, D., Gou, H., Chen, D., Pan, Y., et al. (2023). Targeting m6 A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer. Gut 72, 1497\u20131509.","journal-title":"Gut"},{"key":"2648_CR6","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","volume":"172","author":"JP B\u00f6ttcher","year":"2018","unstructured":"B\u00f6ttcher, J.P., Bonavita, E., Chakravarty, P., Blees, H., Cabeza-Cabrerizo, M., Sammicheli, S., Rogers, N.C., Sahai, E., Zelenay, S., and Reis e Sousa, C. (2018). NK Cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control. Cell 172, 1022\u20131037.e14.","journal-title":"Cell"},{"key":"2648_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11427-022-2340-4","volume":"67","author":"J Cai","year":"2024","unstructured":"Cai, J., Xu, X., and Saw, P.E. (2024). Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance. Sci China Life Sci 67, 19\u201340.","journal-title":"Sci China Life Sci"},{"key":"2648_CR8","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1007\/s11427-022-2161-3","volume":"65","author":"Y Cai","year":"2022","unstructured":"Cai, Y., Song, W., Li, J., Jing, Y., Liang, C., Zhang, L., Zhang, X., Zhang, W., Liu, B., An, Y., et al. (2022). The landscape of aging. Sci China Life Sci 65, 2354\u20132454.","journal-title":"Sci China Life Sci"},{"key":"2648_CR9","doi-asserted-by":"publisher","first-page":"17963","DOI":"10.1021\/ja3064149","volume":"134","author":"B Chen","year":"2012","unstructured":"Chen, B., Ye, F., Yu, L., Jia, G., Huang, X., Zhang, X., Peng, S., Chen, K., Wang, M., Gong, S., et al. (2012). Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor. J Am Chem Soc 134, 17963\u201317971.","journal-title":"J Am Chem Soc"},{"key":"2648_CR10","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1007\/s11427-023-2343-y","volume":"66","author":"G Chen","year":"2023","unstructured":"Chen, G., Sun, L., Gu, X., Ai, L., Yang, J., Zhang, Z., Hou, P., Wang, Y., Ou, X., Jiang, X., et al. (2023a). FSIP1 enhances the therapeutic sensitivity to CDK4\/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway. Sci China Life Sci 66, 2805\u20132817.","journal-title":"Sci China Life Sci"},{"key":"2648_CR11","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1053\/j.gastro.2022.06.024","volume":"163","author":"H Chen","year":"2022","unstructured":"Chen, H., Pan, Y., Zhou, Q., Liang, C., Wong, C.C., Zhou, Y., Huang, D., Liu, W., Zhai, J., Gou, H., et al. (2022). METTL3 inhibits antitumor immunity by targeting m6A-BHLHE41-CXCL1\/CXCR2 axis to promote colorectal cancer. Gastroenterology 163, 891\u2013907.","journal-title":"Gastroenterology"},{"key":"2648_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12943-021-01322-w","volume":"20","author":"H Chen","year":"2021","unstructured":"Chen, H., Yao, J., Bao, R., Dong, Y., Zhang, T., Du, Y., Wang, G., Ni, D., Xun, Z., Niu, X., et al. (2021). Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer. Mol Cancer 20, 29.","journal-title":"Mol Cancer"},{"key":"2648_CR13","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/hep.29683","volume":"67","author":"M Chen","year":"2018","unstructured":"Chen, M., Wei, L., Law, C.T., Tsang, F.H., Shen, J., Cheng, C.L., Tsang, L.H., Ho, D.W., Chiu, D.K., Lee, J.M., et al. (2018a). RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttran-scriptional silencing of SOCS2. Hepatology 67, 2254\u20132270.","journal-title":"Hepatology"},{"key":"2648_CR14","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1158\/2159-8290.CD-15-1545","volume":"6","author":"PL Chen","year":"2016","unstructured":"Chen, P.L., Roh, W., Reuben, A., Cooper, Z.A., Spencer, C.N., Prieto, P.A., Miller, J.P., Bassett, R.L., Gopalakrishnan, V., Wani, K., et al. (2016). Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade. Cancer Discov 6, 827\u2013837.","journal-title":"Cancer Discov"},{"key":"2648_CR15","doi-asserted-by":"publisher","first-page":"5298","DOI":"10.1038\/s41467-018-07545-8","volume":"9","author":"S Chen","year":"2018","unstructured":"Chen, S., Fang, L., Guo, W., Zhou, Y., Yu, G., Li, W., Dong, K., Liu, J., Luo, Y., Wang, B., et al. (2018b). Control of Treg cell homeostasis and immune equilibrium by Lkb1 in dendritic cells. Nat Commun 9, 5298.","journal-title":"Nat Commun"},{"key":"2648_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s11658-023-00445-w","volume":"28","author":"X Chen","year":"2023","unstructured":"Chen, X., Lu, T., Cai, Y., Han, Y., Ding, M., Chu, Y., Zhou, X., and Wang, X. (2023b). KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo\u2013YAP pathway. Cell Mol Biol Lett 28, 32.","journal-title":"Cell Mol Biol Lett"},{"key":"2648_CR17","doi-asserted-by":"publisher","first-page":"e1198","DOI":"10.1002\/ctm2.1198","volume":"13","author":"Y Chen","year":"2023","unstructured":"Chen, Y., Zhou, P., Deng, Y., Cai, X., Sun, M., Sun, Y., and Wu, D. (2023c). ALKBH5-mediated m6A demethylation of TIRAP mRNA promotes radiation-induced liver fibrosis and decreases radiosensitivity of hepatocellular carcinoma. Clin Transl Med 13, e1198.","journal-title":"Clin Transl Med"},{"key":"2648_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13045-020-00854-w","volume":"13","author":"YT Chen","year":"2020","unstructured":"Chen, Y.T., Shen, J.Y., Chen, D.P., Wu, C.F., Guo, R., Zhang, P.P., Lv, J.W., Li, W.F., Wang, Z.X., and Chen, Y.P. (2020). Identification of cross-talk between m6A and 5mC regulators associated with onco-immunogenic features and prognosis across 33 cancer types. J Hematol Oncol 13, 22.","journal-title":"J Hematol Oncol"},{"key":"2648_CR19","doi-asserted-by":"publisher","first-page":"e13400","DOI":"10.1111\/cpr.13400","volume":"56","author":"Z Chen","year":"2023","unstructured":"Chen, Z., Ruan, W., Guo, C., Chen, K., Li, L., Tian, J., Hu, Z., Peng, D., and Zeng, X. (2023d). Non-SMC condensin I complex subunit H participates in anti-programmed cell death-1 resistance of clear cell renal cell carcinomas. Cell Prolif 56, e13400.","journal-title":"Cell Prolif"},{"key":"2648_CR20","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.7150\/thno.52717","volume":"11","author":"W Chong","year":"2021","unstructured":"Chong, W., Shang, L., Liu, J., Fang, Z., Du, F., Wu, H., Liu, Y., Wang, Z., Chen, Y., Jia, S., et al. (2021). m6A regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer. Theranostics 11, 2201\u20132217.","journal-title":"Theranostics"},{"key":"2648_CR21","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41392-022-01175-9","volume":"7","author":"L Cui","year":"2022","unstructured":"Cui, L., Ma, R., Cai, J., Guo, C., Chen, Z., Yao, L., Wang, Y., Fan, R., Wang, X., and Shi, Y. (2022). RNA modifications: importance in immune cell biology and related diseases. Sig Transduct Target Ther 7, 334.","journal-title":"Sig Transduct Target Ther"},{"key":"2648_CR22","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1016\/j.celrep.2017.02.059","volume":"18","author":"Q Cui","year":"2017","unstructured":"Cui, Q., Shi, H., Ye, P., Li, L., Qu, Q., Sun, G., Sun, G., Lu, Z., Huang, Y., Yang, C.G., et al. (2017). m6A RNA methylation regulates the self-renewal and tumorigenesis of glioblastoma stem cells. Cell Rep 18, 2622\u20132634.","journal-title":"Cell Rep"},{"key":"2648_CR23","doi-asserted-by":"publisher","first-page":"e109895","DOI":"10.15252\/embj.2021109895","volume":"41","author":"Y Dagan","year":"2022","unstructured":"Dagan, Y., Yesharim, Y., Bonneau, A.R., Frankovits, T., Schwartz, S., Reddien, P.W., and Wurtzel, O. (2022). m6A is required for resolving progenitor identity during planarian stem cell differentiation. EMBO J 41, e109895.","journal-title":"EMBO J"},{"key":"2648_CR24","doi-asserted-by":"publisher","first-page":"e146133","DOI":"10.1172\/jci.insight.146133","volume":"6","author":"J Deng","year":"2021","unstructured":"Deng, J., Kang, Y., Cheng, C.C., Li, X., Dai, B., Katz, M.H., Men, T., Kim, M.P., Koay, E. A., Huang, H., et al. (2021). DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis. JCI Insight 6, e146133.","journal-title":"JCI Insight"},{"key":"2648_CR25","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1073\/pnas.71.10.3971","volume":"71","author":"R Desrosiers","year":"1974","unstructured":"Desrosiers, R., Friderici, K., and Rottman, F. (1974). Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci USA 71, 3971\u20133975.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2648_CR26","doi-asserted-by":"publisher","first-page":"e2203318119","DOI":"10.1073\/pnas.2203318119","volume":"119","author":"C Ding","year":"2022","unstructured":"Ding, C., Xu, H., Yu, Z., Roulis, M., Qu, R., Zhou, J., Oh, J., Crawford, J., Gao, Y., Jackson, R., et al. (2022). RNA m6A demethylase ALKBH5 regulates the development of \u03b3\u03b4 T cells. Proc Natl Acad Sci USA 119, e2203318119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2648_CR27","doi-asserted-by":"publisher","first-page":"5876","DOI":"10.1158\/0008-5472.CAN-21-1456","volume":"81","author":"F Dong","year":"2021","unstructured":"Dong, F., Qin, X., Wang, B., Li, Q., Hu, J., Cheng, X., Guo, D., Cheng, F., Fang, C., Tan, Y., et al. (2021a). ALKBH5 facilitates hypoxia-induced paraspeckle assembly and IL8 secretion to generate an immunosuppressive tumor microenvironment. Cancer Res 81, 5876\u20135888.","journal-title":"Cancer Res"},{"key":"2648_CR28","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.ccell.2021.04.016","volume":"39","author":"L Dong","year":"2021","unstructured":"Dong, L., Chen, C., Zhang, Y., Guo, P., Wang, Z., Li, J., Liu, Y., Liu, J., Chang, R., Li, Y., et al. (2021b). The loss of RNA N6-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8+ T cell dysfunction and tumor growth. Cancer Cell 39, 945\u2013957.e10.","journal-title":"Cancer Cell"},{"key":"2648_CR29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41571-021-00473-5","volume":"18","author":"DB Doroshow","year":"2021","unstructured":"Doroshow, D.B., Bhalla, S., Beasley, M.B., Sholl, L.M., Kerr, K.M., Gnjatic, S., Wistuba, I.I., Rimm, D.L., Tsao, M.S., and Hirsch, F.R. (2021). PD-L1 as a biomarker of response to immune-checkpoint inhibitors. Nat Rev Clin Oncol 18, 345\u2013362.","journal-title":"Nat Rev Clin Oncol"},{"key":"2648_CR30","doi-asserted-by":"publisher","first-page":"12626","DOI":"10.1038\/ncomms12626","volume":"7","author":"H Du","year":"2016","unstructured":"Du, H., Zhao, Y., He, J., Zhang, Y., Xi, H., Liu, M., Ma, J., and Wu, L. (2016). YTHDF2 destabilizes m6A-containing RNA through direct recruitment of the CCR4\u2013NOT deadenylase complex. Nat Commun 7, 12626.","journal-title":"Nat Commun"},{"key":"2648_CR31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.devcel.2020.10.023","volume":"55","author":"J Du","year":"2020","unstructured":"Du, J., Liao, W., Liu, W., Deb, D.K., He, L., Hsu, P.J., Nguyen, T., Zhang, L., Bissonnette, M., He, C., et al. (2020). N6-adenosine methylation of SOCS1 mRNA is required to sustain the negative feedback control of macrophage activation. Dev Cell 55, 737\u2013753.e7.","journal-title":"Dev Cell"},{"key":"2648_CR32","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1007\/s11427-023-2417-3","volume":"67","author":"C Fan","year":"2024","unstructured":"Fan, C., Xiong, F., Zhang, S., Gong, Z., Liao, Q., Li, G., Guo, C., Xiong, W., Huang, H., and Zeng, Z. (2024). Role of adhesion molecules in cancer and targeted therapy. Sci China Life Sci 67, 940\u2013957.","journal-title":"Sci China Life Sci"},{"key":"2648_CR33","doi-asserted-by":"publisher","first-page":"114446","DOI":"10.1016\/j.ejmech.2022.114446","volume":"238","author":"Z Fang","year":"2022","unstructured":"Fang, Z., Mu, B., Liu, Y., Guo, N., Xiong, L., Guo, Y., Xia, A., Zhang, R., Zhang, H., Yao, R., et al. (2022). Discovery of a potent, selective and cell active inhibitor of m6A demethylase ALKBH5. Eur J Med Chem 238, 114446.","journal-title":"Eur J Med Chem"},{"key":"2648_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1021\/cc900152y","volume":"12","author":"M Fantini","year":"2010","unstructured":"Fantini, M., Zuliani, V., Spotti, M.A., and Rivara, M. (2010). Microwave assisted efficient synthesis of imidazole-based privileged structures. J Comb Chem 12, 181\u2013185.","journal-title":"J Comb Chem"},{"key":"2648_CR35","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1038\/s41388-023-02760-0","volume":"42","author":"J Gao","year":"2023","unstructured":"Gao, J., Fang, Y., Chen, J., Tang, Z., Tian, M., Jiang, X., Tao, C., Huang, R., Zhu, G., Qu, W., et al. (2023). Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy. Oncogene 42, 2507\u20132520.","journal-title":"Oncogene"},{"key":"2648_CR36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.omto.2021.06.017","volume":"23","author":"Y Gao","year":"2021","unstructured":"Gao, Y., Ouyang, X., Zuo, L., Xiao, Y., Sun, Y., Chang, C., Qin, X., and Yeh, S. (2021). R-2HG downregulates ER\u03b1 to inhibit cholangiocarcinoma via the FTO\/m6A-methylated ER\u03b1\/miR16-5p\/YAP1 signal pathway. Mol Ther-Oncolytics 23, 65\u201381.","journal-title":"Mol Ther-Oncolytics"},{"key":"2648_CR37","doi-asserted-by":"publisher","first-page":"e1618","DOI":"10.1002\/wrna.1618","volume":"12","author":"D Garcias Morales","year":"2021","unstructured":"Garcias Morales, D., and Reyes, J.L. (2021). A birds\u2019-eye view of the activity and specificity of the mRNA m6A methyltransferase complex. WIREs RNA 12, e1618.","journal-title":"WIREs RNA"},{"key":"2648_CR38","doi-asserted-by":"publisher","first-page":"5919","DOI":"10.3390\/cancers14235919","volume":"14","author":"R Garg","year":"2022","unstructured":"Garg, R., Melstrom, L., Chen, J., He, C., and Goel, A. (2022). Targeting FTO suppresses pancreatic carcinogenesis via regulating stem cell maintenance and EMT pathway. Cancers 14, 5919.","journal-title":"Cancers"},{"key":"2648_CR39","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/ni.3324","volume":"17","author":"F Ginhoux","year":"2016","unstructured":"Ginhoux, F., Schultze, J.L., Murray, P.J., Ochando, J., and Biswas, S.K. (2016). New insights into the multidimensional concept of macrophage ontogeny, activation and function. Nat Immunol 17, 34\u201340.","journal-title":"Nat Immunol"},{"key":"2648_CR40","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s11427-022-2104-3","volume":"65","author":"C Gong","year":"2022","unstructured":"Gong, C., Cheng, Z., Yang, Y., Shen, J., Zhu, Y., Ling, L., Lin, W., Yu, Z., Li, Z., Tan, W., et al. (2022). A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer. Sci China Life Sci 65, 2205\u20132217.","journal-title":"Sci China Life Sci"},{"key":"2648_CR41","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semcancer.2019.12.012","volume":"68","author":"A Gonzalez-Fierro","year":"2021","unstructured":"Gonzalez-Fierro, A., and Due\u00f1as-Gonz\u00e1lez, A. (2021). Drug repurposing for cancer therapy, easier said than done. Semin Cancer Biol 68, 123\u2013131.","journal-title":"Semin Cancer Biol"},{"key":"2648_CR42","doi-asserted-by":"publisher","first-page":"109553","DOI":"10.1016\/j.cellsig.2020.109553","volume":"69","author":"X Gu","year":"2020","unstructured":"Gu, X., Zhang, Y., Li, D., Cai, H., Cai, L., and Xu, Q. (2020). N6-methyladenosine demethylase FTO promotes M1 and M2 macrophage activation. Cell Signal 69, 109553.","journal-title":"Cell Signal"},{"key":"2648_CR43","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41419-023-05570-0","volume":"14","author":"H Guan","year":"2023","unstructured":"Guan, H., Tian, K., Luo, W., and Li, M. (2023). m6A-modified circRNA MYO1C participates in the tumor immune surveillance of pancreatic ductal adenocarcinoma through m6A\/PD-L1 manner. Cell Death Dis 14, 120.","journal-title":"Cell Death Dis"},{"key":"2648_CR44","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-023-01792-0","volume":"22","author":"S Hagemann","year":"2023","unstructured":"Hagemann, S., Misiak, D., Bell, J.L., Fuchs, T., Lederer, M.I., Bley, N., H\u00e4mmerle, M., Ghazy, E., Sippl, W., Schulte, J.H., et al. (2023). IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression. Mol Cancer 22, 88.","journal-title":"Mol Cancer"},{"key":"2648_CR45","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-0916-x","volume":"566","author":"D Han","year":"2019","unstructured":"Han, D., Liu, J., Chen, C., Dong, L., Liu, Y., Chang, R., Huang, X., Liu, Y., Wang, J., Dougherty, U., et al. (2019). Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells. Nature 566, 270\u2013274.","journal-title":"Nature"},{"key":"2648_CR46","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nature20577","volume":"540","author":"IU Haussmann","year":"2016","unstructured":"Haussmann, I.U., Bodi, Z., Sanchez-Moran, E., Mongan, N.P., Archer, N., Fray, R.G., and Soller, M. (2016). m6A potentiates Sxl alternative pre-mRNA splicing for robust Drosophila sex determination. Nature 540, 301\u2013304.","journal-title":"Nature"},{"key":"2648_CR47","doi-asserted-by":"publisher","first-page":"7341","DOI":"10.1021\/acs.jmedchem.5b00702","volume":"58","author":"W He","year":"2015","unstructured":"He, W., Zhou, B., Liu, W., Zhang, M., Shen, Z., Han, Z., Jiang, Q., Yang, Q., Song, C., Wang, R., et al. (2015). Identification of a novel small-molecule binding site of the fat mass and obesity associated protein (FTO). J Med Chem 58, 7341\u20137348.","journal-title":"J Med Chem"},{"key":"2648_CR48","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1158\/1078-0432.CCR-20-3305","volume":"27","author":"MD Hellmann","year":"2021","unstructured":"Hellmann, M.D., J\u00e4nne, P.A., Opyrchal, M., Hafez, N., Raez, L.E., Gabrilovich, D.I., Wang, F., Trepel, J.B., Lee, M.J., Yuno, A., et al. (2021). Entinostat plus pembrolizumab in patients with metastatic NSCLC previously treated with anti\u2013PD-(L)1 therapy. Clin Cancer Res 27, 1019\u20131028.","journal-title":"Clin Cancer Res"},{"key":"2648_CR49","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1172\/JCI129338","volume":"129","author":"JJ Hodgins","year":"2019","unstructured":"Hodgins, J.J., Khan, S.T., Park, M.M., Auer, R.C., and Ardolino, M. (2019). Killers 2.0: NK cell therapies at the forefront of cancer control. J Clin Invest 129, 3499\u20133510.","journal-title":"J Clin Invest"},{"key":"2648_CR50","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/cr.2017.99","volume":"27","author":"PJ Hsu","year":"2017","unstructured":"Hsu, P.J., Zhu, Y., Ma, H., Guo, Y., Shi, X., Liu, Y., Qi, M., Lu, Z., Shi, H., Wang, J., et al. (2017). YTHDC2 is an N6-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res 27, 1115\u20131127.","journal-title":"Cell Res"},{"key":"2648_CR51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12943-023-01759-1","volume":"22","author":"Z Hu","year":"2023","unstructured":"Hu, Z., Chen, G., Zhao, Y., Gao, H., Li, L., Yin, Y., Jiang, J., Wang, L., Mang, Y., Gao, Y., et al. (2023). Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. Mol Cancer 22, 55.","journal-title":"Mol Cancer"},{"key":"2648_CR52","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13045-021-01129-8","volume":"14","author":"W Huang","year":"2021","unstructured":"Huang, W., Chen, T.Q., Fang, K., Zeng, Z.C., Ye, H., and Chen, Y.Q. (2021). N6-methyladenosine methyltransferases: functions, regulation, and clinical potential. J Hematol Oncol 14, 117.","journal-title":"J Hematol Oncol"},{"key":"2648_CR53","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ccell.2019.03.006","volume":"35","author":"Y Huang","year":"2019","unstructured":"Huang, Y., Su, R., Sheng, Y., Dong, L., Dong, Z., Xu, H., Ni, T., Zhang, Z.S., Zhang, T., Li, C., et al. (2019). Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia. Cancer Cell 35, 677\u2013691.e10.","journal-title":"Cancer Cell"},{"key":"2648_CR54","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/nar\/gku1276","volume":"43","author":"Y Huang","year":"2015","unstructured":"Huang, Y., Yan, J., Li, Q., Li, J., Gong, S., Zhou, H., Gan, J., Jiang, H., Jia, G.F., Luo, C., et al. (2015). Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5. Nucleic Acids Res 43, 373\u2013384.","journal-title":"Nucleic Acids Res"},{"key":"2648_CR55","doi-asserted-by":"publisher","first-page":"10920","DOI":"10.1021\/acs.jmedchem.1c02075","volume":"65","author":"S Huff","year":"2022","unstructured":"Huff, S., Kummetha, I.R., Zhang, L., Wang, L., Bray, W., Yin, J., Kelley, V., Wang, Y., and Rana, T.M. (2022). Rational design and optimization of m6A-RNA demethylase FTO inhibitors as anticancer agents. J Med Chem 65, 10920\u201310937.","journal-title":"J Med Chem"},{"key":"2648_CR56","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1021\/acschembio.0c00841","volume":"16","author":"S Huff","year":"2021","unstructured":"Huff, S., Tiwari, S.K., Gonzalez, G.M., Wang, Y., and Rana, T.M. (2021). m6A-RNA demethylase FTO inhibitors impair self-renewal in glioblastoma stem cells. ACS Chem Biol 16, 324\u2013333.","journal-title":"ACS Chem Biol"},{"key":"2648_CR57","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1101\/gad.333369.119","volume":"34","author":"VV Ignatova","year":"2020","unstructured":"Ignatova, V.V., Stolz, P., Kaiser, S., Gustafsson, T.H., Lastres, P.R., Sanz-Moreno, A., Cho, Y.L., Amarie, O.V., Aguilar-Pimentel, A., Klein-Rodewald, T., et al. (2020). The rRNA m6A methyltransferase METTL5 is involved in pluripotency and developmental programs. Genes Dev 34, 715\u2013729.","journal-title":"Genes Dev"},{"key":"2648_CR58","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41590-022-01268-1","volume":"23","author":"T Ito-Kureha","year":"2022","unstructured":"Ito-Kureha, T., Leoni, C., Borland, K., Cantini, G., Bataclan, M., Metzger, R.N., Ammann, G., Krug, A.B., Marsico, A., Kaiser, S., et al. (2022). The function of Wtap in N6-adenosine methylation of mRNAs controls T cell receptor signaling and survival of T cells. Nat Immunol 23, 1208\u20131221.","journal-title":"Nat Immunol"},{"key":"2648_CR59","doi-asserted-by":"publisher","first-page":"103569","DOI":"10.1016\/j.sjbs.2023.103569","volume":"30","author":"A Jamal","year":"2023","unstructured":"Jamal, A., Hassan Dalhat, M., Jahan, S., Choudhry, H., and Imran Khan, M. (2023). BTYNB, an inhibitor of RNA binding protein IGF2BP1 reduces proliferation and induces differentiation of leukemic cancer cells. Saudi J Biol Sci 30, 103569.","journal-title":"Saudi J Biol Sci"},{"key":"2648_CR60","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12943-022-01572-2","volume":"21","author":"S Jin","year":"2022","unstructured":"Jin, S., Li, M., Chang, H., Wang, R., Zhang, Z., Zhang, J., He, Y., and Ma, H. (2022). The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKK\u03b5\/TBK1\/IRF3 pathway in head and neck squamous cell carcinoma. Mol Cancer 21, 97.","journal-title":"Mol Cancer"},{"key":"2648_CR61","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","volume":"20","author":"A Kalbasi","year":"2020","unstructured":"Kalbasi, A., and Ribas, A. (2020). Tumour-intrinsic resistance to immune checkpoint blockade. Nat Rev Immunol 20, 25\u201339.","journal-title":"Nat Rev Immunol"},{"key":"2648_CR62","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.devcel.2021.03.006","volume":"56","author":"H Kim","year":"2021","unstructured":"Kim, H., Lee, Y., Kim, S.M., Jang, S., Choi, H., Lee, J.W., Kim, T.D., and Kim, V.N. (2021). RNA demethylation by FTO stabilizes the FOXJ1 mRNA for proper motile ciliogenesis. Dev Cell 56, 1118\u20131130.e6.","journal-title":"Dev Cell"},{"key":"2648_CR63","doi-asserted-by":"publisher","first-page":"e55681","DOI":"10.15252\/embr.202255681","volume":"24","author":"SM Kim","year":"2023","unstructured":"Kim, S.M., Oh, S.C., Lee, S.Y., Kong, L.Z., Lee, J.H., and Kim, T.D. (2023). FTO negatively regulates the cytotoxic activity of natural killer cells. EMBO Rep 24, e55681.","journal-title":"EMBO Rep"},{"key":"2648_CR64","first-page":"100452","volume":"4","author":"Y Kong","year":"2023","unstructured":"Kong, Y., Yu, J., Ge, S., and Fan, X. (2023). Novel insight into RNA modifications in tumor immunity: promising targets to prevent tumor immune escape. Innovation 4, 100452.","journal-title":"Innovation"},{"key":"2648_CR65","doi-asserted-by":"publisher","first-page":"S364","DOI":"10.1016\/j.jaci.2007.06.016","volume":"121","author":"D Larosa","year":"2008","unstructured":"Larosa, D., and Orange, J. (2008). 1. Lymphocytes. J Allergy Clin Immunol 121, S364\u2013S369. quiz S412.","journal-title":"J Allergy Clin Immunol"},{"key":"2648_CR66","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/cr.2017.10","volume":"27","author":"A Li","year":"2017","unstructured":"Li, A., Chen, Y.S., Ping, X.L., Yang, X., Xiao, W., Yang, Y., Sun, H.Y., Zhu, Q., Baidya, P., Wang, X., et al. (2017a). Cytoplasmic m6A reader YTHDF3 promotes mRNA translation. Cell Res 27, 444\u2013447.","journal-title":"Cell Res"},{"key":"2648_CR67","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature23450","volume":"548","author":"HB Li","year":"2017","unstructured":"Li, H.B., Tong, J., Zhu, S., Batista, P.J., Duffy, E.E., Zhao, J., Bailis, W., Cao, G., Kroehling, L., Chen, Y., et al. (2017b). m6A mRNA methylation controls T cell homeostasis by targeting the IL-7\/STAT5\/SOCS pathways. Nature 548, 338\u2013342.","journal-title":"Nature"},{"key":"2648_CR68","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nri.2016.26","volume":"16","author":"MO Li","year":"2016","unstructured":"Li, M.O., and Rudensky, A.Y. (2016). T cell receptor signalling in the control of regulatory T cell differentiation and function. Nat Rev Immunol 16, 220\u2013233.","journal-title":"Nat Rev Immunol"},{"key":"2648_CR69","doi-asserted-by":"publisher","first-page":"20159","DOI":"10.1073\/pnas.1918986117","volume":"117","author":"N Li","year":"2020","unstructured":"Li, N., Kang, Y., Wang, L., Huff, S., Tang, R., Hui, H., Agrawal, K., Gonzalez, G.M., Wang, Y., Patel, S.P., et al. (2020). ALKBH5 regulates anti\u2013PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment. Proc Natl Acad Sci USA 117, 20159\u201320170.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2648_CR70","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1136\/gutjnl-2022-326928","volume":"72","author":"T Li","year":"2023","unstructured":"Li, T., Tan, Y.T., Chen, Y.X., Zheng, X.J., Wang, W., Liao, K., Mo, H.Y., Lin, J., Yang, W., Piao, H.L., et al. (2023). Methionine deficiency facilitates antitumour immunity by altering m6A methylation of immune checkpoint transcripts. Gut 72, 501\u2013511.","journal-title":"Gut"},{"key":"2648_CR71","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1111\/cas.15332","volume":"113","author":"X Li","year":"2022","unstructured":"Li, X., Chen, W., Gao, Y., Song, J., Gu, Y., Zhang, J., Cheng, X., and Ai, Y. (2022). Fat mass and obesity-associated protein regulates arecoline-exposed oral cancer immune response through programmed cell death-ligand 1. Cancer Sci 113, 2962\u20132973.","journal-title":"Cancer Sci"},{"key":"2648_CR72","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s10020-023-00696-5","volume":"29","author":"B Lian","year":"2023","unstructured":"Lian, B., Yan, S., Li, J., Bai, Z., and Li, J. (2023). HNRNPC promotes collagen fiber alignment and immune evasion in breast cancer via activation of the VIRMA-mediated TFAP2A\/DDR1 axis. Mol Med 29, 103.","journal-title":"Mol Med"},{"key":"2648_CR73","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1158\/2326-6066.CIR-22-0814","volume":"11","author":"W Liang","year":"2023","unstructured":"Liang, W., Liu, H., Zeng, Z., Liang, Z., Xie, H., Li, W., Xiong, L., Liu, Z., Chen, M., Jie, H., et al. (2023). KRT17 promotes T-lymphocyte infiltration through the YTHDF2\u2013CXCL10 axis in colorectal cancer. Cancer Immunol Res 11, 875\u2013894.","journal-title":"Cancer Immunol Res"},{"key":"2648_CR74","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41467-022-35710-7","volume":"14","author":"W Lin","year":"2023","unstructured":"Lin, W., Chen, L., Zhang, H., Qiu, X., Huang, Q., Wan, F., Le, Z., Geng, S., Zhang, A., Qiu, S., et al. (2023). Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation. Nat Commun 14, 265.","journal-title":"Nat Commun"},{"key":"2648_CR75","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nchembio.1432","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu, J., Yue, Y., Han, D., Wang, X., Fu, Y., Zhang, L., Jia, G., Yu, M., Lu, Z., Deng, X., et al. (2014). A METTL3\u2013METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol 10, 93\u201395.","journal-title":"Nat Chem Biol"},{"key":"2648_CR76","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.immuni.2019.01.021","volume":"50","author":"J Liu","year":"2019","unstructured":"Liu, J., Zhang, X., Chen, K., Cheng, Y., Liu, S., Xia, M., Chen, Y., Zhu, H., Li, Z., and Cao, X. (2019a). CCR7 chemokine receptor-inducible Inc-Dpf3 restrains dendritic cell migration by inhibiting HIF-1\u03b1-mediated glycolysis. Immunity 50, 600\u2013615.e15.","journal-title":"Immunity"},{"key":"2648_CR77","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1021\/acscentsci.2c00107","volume":"8","author":"Y Liu","year":"2022","unstructured":"Liu, Y., Guo, Q., Yang, H., Zhang, X.W., Feng, N., Wang, J.K., Liu, T.T., Zeng, K.W., and Tu, P.F. (2022a). Allosteric regulation of IGF2BP1 as a novel strategy for the activation of tumor immune microenvironment. ACS Cent Sci 8, 1102\u20131115.","journal-title":"ACS Cent Sci"},{"key":"2648_CR78","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.cmet.2021.04.001","volume":"33","author":"Y Liu","year":"2021","unstructured":"Liu, Y., Liang, G., Xu, H., Dong, W., Dong, Z., Qiu, Z., Zhang, Z., Li, F., Huang, Y., Li, Y., et al. (2021a). Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance. Cell Metab 33, 1221\u20131233.e11.","journal-title":"Cell Metab"},{"key":"2648_CR79","doi-asserted-by":"publisher","first-page":"C762","DOI":"10.1152\/ajpcell.00212.2019","volume":"317","author":"Y Liu","year":"2019","unstructured":"Liu, Y., Liu, Z., Tang, H., Shen, Y., Gong, Z., Xie, N., Zhang, X., Wang, W., Kong, W., Zhou, Y., et al. (2019b). The N6-methyladenosine (m6A)-forming enzyme METTL3 facilitates M1 macrophage polarization through the methylation of STAT1 mRNA. Am J Physiol Cell Physiol 317, C762\u2013C775.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2648_CR80","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-021-01398-4","volume":"20","author":"Z Liu","year":"2021","unstructured":"Liu, Z., Wang, T., She, Y., Wu, K., Gu, S., Li, L., Dong, C., Chen, C., and Zhou, Y. (2021b). N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Mol Cancer 20, 105.","journal-title":"Mol Cancer"},{"key":"2648_CR81","doi-asserted-by":"publisher","first-page":"100886","DOI":"10.1016\/j.drup.2022.100886","volume":"65","author":"Z Liu","year":"2022","unstructured":"Liu, Z., Zheng, N., Li, J., Li, C., Zheng, D., Jiang, X., Ge, X., Liu, M., Liu, L., Song, Z., et al. (2022b). N6-methyladenosine-modified circular RNA QSOX1 promotes color-ectal cancer resistance to anti-CTLA-4 therapy through induction of intratumoral regulatory T cells. Drug Resist Updat 65, 100886.","journal-title":"Drug Resist Updat"},{"key":"2648_CR82","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1038\/s41388-022-02214-z","volume":"41","author":"D Lv","year":"2022","unstructured":"Lv, D., Ding, S., Zhong, L., Tu, J., Li, H., Yao, H., Zou, Y., Zeng, Z., Liao, Y., Wan, X., et al. (2022). M6A demethylase FTO-mediated downregulation of DACT1 mRNA stability promotes Wnt signaling to facilitate osteosarcoma progression. Oncogene 41, 1727\u20131741.","journal-title":"Oncogene"},{"key":"2648_CR83","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41589-018-0184-3","volume":"15","author":"H Ma","year":"2019","unstructured":"Ma, H., Wang, X., Cai, J., Dai, Q., Natchiar, S.K., Lv, R., Chen, K., Lu, Z., Chen, H., Shi, Y.G., et al. (2019). N6-methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation. Nat Chem Biol 15, 88\u201394.","journal-title":"Nat Chem Biol"},{"key":"2648_CR84","doi-asserted-by":"publisher","first-page":"e20210279","DOI":"10.1084\/jem.20210279","volume":"218","author":"S Ma","year":"2021","unstructured":"Ma, S., Yan, J., Barr, T., Zhang, J., Chen, Z., Wang, L.S., Sun, J.C., Chen, J., Caligiuri, M.A., and Yu, J. (2021). The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity. J Exp Med 218, e20210279.","journal-title":"J Exp Med"},{"key":"2648_CR85","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.tranon.2017.07.008","volume":"10","author":"L Mahapatra","year":"2017","unstructured":"Mahapatra, L., Andruska, N., Mao, C., Le, J., and Shapiro, D.J. (2017). A novel IMP1 inhibitor, BTYNB, targets c-Myc and inhibits melanoma and ovarian cancer cell proliferation. Transl Oncol 10, 818\u2013827.","journal-title":"Transl Oncol"},{"key":"2648_CR86","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/biology11010070","volume":"11","author":"A Malacrida","year":"2022","unstructured":"Malacrida, A., Di Domizio, A., Bentivegna, A., Cislaghi, G., Messuti, E., Tabano, S.M., Giussani, C., Zuliani, V., Rivara, M., and Nicolini, G. (2022). MV1035 overcomes temozolomide resistance in patient-derived glioblastoma stem cell lines. Biology 11, 70.","journal-title":"Biology"},{"key":"2648_CR87","doi-asserted-by":"publisher","first-page":"115300","DOI":"10.1016\/j.bmc.2019.115300","volume":"28","author":"A Malacrida","year":"2020","unstructured":"Malacrida, A., Rivara, M., Di Domizio, A., Cislaghi, G., Miloso, M., Zuliani, V., and Nicolini, G. (2020). 3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line. Bioorg Med Chem 28, 115300.","journal-title":"Bioorg Med Chem"},{"key":"2648_CR88","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41589-019-0231-8","volume":"15","author":"J Mauer","year":"2019","unstructured":"Mauer, J., Sindelar, M., Despic, V., Guez, T., Hawley, B.R., Vasseur, J.J., Rentmeister, A., Gross, S.S., Pellizzoni, L., Debart, F., et al. (2019). FTO controls reversible m6Am RNA methylation during snRNA biogenesis. Nat Chem Biol 15, 340\u2013347.","journal-title":"Nat Chem Biol"},{"key":"2648_CR89","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","volume":"149","author":"KD Meyer","year":"2012","unstructured":"Meyer, K.D., Saletore, Y., Zumbo, P., Elemento, O., Mason, C.E., and Jaffrey, S.R. (2012). Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2032 UTRs and near stop codons. Cell 149, 1635\u20131646.","journal-title":"Cell"},{"key":"2648_CR90","doi-asserted-by":"publisher","first-page":"8576","DOI":"10.1093\/nar\/gkaa653","volume":"48","author":"S M\u00fcller","year":"2020","unstructured":"M\u00fcller, S., Bley, N., Busch, B., Gla\u00df, M., Lederer, M., Misiak, C., Fuchs, T., Wedler, A., Haase, J., Bertoldo, J.B., et al. (2020). The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancer. Nucleic Acids Res 48, 8576\u20138590.","journal-title":"Nucleic Acids Res"},{"key":"2648_CR91","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","volume":"79","author":"PJ Murray","year":"2017","unstructured":"Murray, P.J. (2017). Macrophage polarization. Annu Rev Physiol 79, 541\u2013566.","journal-title":"Annu Rev Physiol"},{"key":"2648_CR92","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1158\/0008-5472.CAN-21-1323","volume":"82","author":"Z Ni","year":"2022","unstructured":"Ni, Z., Sun, P., Zheng, J., Wu, M., Yang, C., Cheng, M., Yin, M., Cui, C., Wang, G., Yuan, L., et al. (2022). JNK signaling promotes bladder cancer immune escape by regulating METTL3-mediated m6A modification of PD-L1 mRNA. Cancer Res 82, 1789\u20131802.","journal-title":"Cancer Res"},{"key":"2648_CR93","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1038\/s41418-023-01217-x","volume":"30","author":"J Ning","year":"2023","unstructured":"Ning, J., Hou, X., Hao, J., Zhang, W., Shi, Y., Huang, Y., Ruan, X., Zheng, X., and Gao, M. (2023). METTL3 inhibition induced by M2 macrophage-derived extracellular vesicles drives anti-PD-1 therapy resistance via m6A-CD70-mediated immune suppression in thyroid cancer. Cell Death Differ 30, 2265\u20132279.","journal-title":"Cell Death Differ"},{"key":"2648_CR94","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1021\/acs.biomac.1c01571","volume":"23","author":"Z Ouyang","year":"2022","unstructured":"Ouyang, Z., Gao, Y., Yang, R., Shen, M., and Shi, X. (2022). Genetic engineering of dendritic cells using partially zwitterionic dendrimer-entrapped gold nanoparticles boosts efficient tumor immunotherapy. Biomacromolecules 23, 1326\u20131336.","journal-title":"Biomacromolecules"},{"key":"2648_CR95","doi-asserted-by":"publisher","first-page":"101144","DOI":"10.1016\/j.xcrm.2023.101144","volume":"4","author":"Y Pan","year":"2023","unstructured":"Pan, Y., Chen, H., Zhang, X., Liu, W., Ding, Y., Huang, D., Zhai, J., Wei, W., Wen, J., Chen, D., et al. (2023). METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy. Cell Rep Med 4, 101144.","journal-title":"Cell Rep Med"},{"key":"2648_CR96","doi-asserted-by":"publisher","first-page":"e004495","DOI":"10.1136\/jitc-2022-004495","volume":"10","author":"D Papadatos-Pastos","year":"2022","unstructured":"Papadatos-Pastos, D., Yuan, W., Pal, A., Crespo, M., Ferreira, A., Gurel, B., Prout, T., Ameratunga, M., Ch\u00e9nard-Poirier, M., Curcean, A., et al. (2022). Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors. J Immunother Cancer 10, e004495.","journal-title":"J Immunother Cancer"},{"key":"2648_CR97","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.cell.2017.05.003","volume":"169","author":"KE Pendleton","year":"2017","unstructured":"Pendleton, K.E., Chen, B., Liu, K., Hunter, O.V., Xie, Y., Tu, B.P., and Conrad, N.K. (2017). The U6 snRNA m6A methyltransferase METTL16 regulates SAM synthetase intron retention. Cell 169, 824\u2013835.e14.","journal-title":"Cell"},{"key":"2648_CR98","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s10565-022-09718-0","volume":"38","author":"L Peng","year":"2022","unstructured":"Peng, L., Pan, B., Zhang, X., Wang, Z., Qiu, J., Wang, X., and Tang, N. (2022). Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expression. Cell Biol Toxicol 38, 1159\u20131173.","journal-title":"Cell Biol Toxicol"},{"key":"2648_CR99","doi-asserted-by":"publisher","first-page":"eaau7116","DOI":"10.1126\/scitranslmed.aau7116","volume":"11","author":"S Peng","year":"2019","unstructured":"Peng, S., Xiao, W., Ju, D., Sun, B., Hou, N., Liu, Q., Wang, Y., Zhao, H., Gao, C., Zhang, S., et al. (2019). Identification of entacapone as a chemical inhibitor of FTO mediating metabolic regulation through FOXO1. Sci Transl Med 11, eaau7116.","journal-title":"Sci Transl Med"},{"key":"2648_CR100","doi-asserted-by":"publisher","first-page":"1087644","DOI":"10.3389\/fonc.2023.1087644","volume":"13","author":"T Phan","year":"2023","unstructured":"Phan, T., Nguyen, V.H., Su, R., Li, Y., Qing, Y., Qin, H., Cho, H., Jiang, L., Wu, X., Chen, J., et al. (2023). Targeting fat mass and obesity-associated protein mitigates human colorectal cancer growth in vitro and in a murine model. Front Oncol 13, 1087644.","journal-title":"Front Oncol"},{"key":"2648_CR101","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1021\/acs.biochem.6b00023","volume":"55","author":"Y Qiao","year":"2016","unstructured":"Qiao, Y., Zhou, B., Zhang, M., Liu, W., Han, Z., Song, C., Yu, W., Yang, Q., Wang, R., Wang, S., et al. (2016). A novel inhibitor of the obesity-related protein FTO. Biochemistry 55, 1516\u20131522.","journal-title":"Biochemistry"},{"key":"2648_CR102","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.molcel.2020.12.026","volume":"81","author":"Y Qing","year":"2021","unstructured":"Qing, Y., Dong, L., Gao, L., Li, C., Li, Y., Han, L., Prince, E., Tan, B., Deng, X., Wetzel, C., et al. (2021). R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO\/m6A\/PFKP\/LDHB axis. Mol Cell 81, 922\u2013939.e9.","journal-title":"Mol Cell"},{"key":"2648_CR103","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1158\/0008-5472.CAN-21-0468","volume":"81","author":"X Qiu","year":"2021","unstructured":"Qiu, X., Yang, S., Wang, S., Wu, J., Zheng, B., Wang, K., Shen, S., Jeong, S., Li, Z., Zhu, Y., et al. (2021). M6A demethylase ALKBH5 regulates PD-L1 expression and tumor immunoenvironment in intrahepatic cholangiocarcinoma. Cancer Res 81, 4778\u20134793.","journal-title":"Cancer Res"},{"key":"2648_CR104","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1158\/2159-8290.CD-20-1848","volume":"12","author":"Z Qiu","year":"2022","unstructured":"Qiu, Z., Zhao, L., Shen, J.Z., Liang, Z., Wu, Q., Yang, K., Min, L., Gimple, R.C., Yang, Q., Bhargava, S., et al. (2022). Transcription elongation machinery is a druggable dependency and potentiates immunotherapy in glioblastoma stem cells. Cancer Discov 12, 502\u2013521.","journal-title":"Cancer Discov"},{"key":"2648_CR105","doi-asserted-by":"publisher","first-page":"e1759","DOI":"10.1002\/cnr2.1759","volume":"6","author":"F Ramedani","year":"2023","unstructured":"Ramedani, F., Jafari, S.M., Saghaeian Jazi, M., Mohammadi, Z., and Asadi, J. (2023). Anti-cancer effect of entacaponeon esophageal cancer cells via apoptosis induction and cell cycle modulation. Cancer Rep 6, e1759.","journal-title":"Cancer Rep"},{"key":"2648_CR106","doi-asserted-by":"publisher","first-page":"e20202077","DOI":"10.1084\/jem.20202077","volume":"218","author":"GJ Randolph","year":"2021","unstructured":"Randolph, G.J. (2021). Dendritic cells: the first step. J Exp Med 218, e20202077.","journal-title":"J Exp Med"},{"key":"2648_CR107","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1038\/s41467-021-21758-4","volume":"12","author":"S Relier","year":"2021","unstructured":"Relier, S., Ripoll, J., Guillorit, H., Amalric, A., Achour, C., Boissi\u00e8re, F., Vialaret, J., Attina, A., Debart, F., Choquet, A., et al. (2021). FTO-mediated cytoplasmic m6Am demethylation adjusts stem-like properties in colorectal cancer cell. Nat Commun 12, 1716.","journal-title":"Nat Commun"},{"key":"2648_CR108","doi-asserted-by":"publisher","first-page":"5042","DOI":"10.1038\/s41467-019-12923-x","volume":"10","author":"W Ren","year":"2019","unstructured":"Ren, W., Lu, J., Huang, M., Gao, L., Li, D., Wang, G.G., and Song, J. (2019). Structure and regulation of ZCCHC4 in m6A-methylation of 28S rRNA. Nat Commun 10, 5042.","journal-title":"Nat Commun"},{"key":"2648_CR109","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41577-020-00452-4","volume":"21","author":"JC Ribot","year":"2021","unstructured":"Ribot, J.C., Lopes, N., and Silva-Santos, B. (2021). \u03b3\u03b4 T cells in tissue physiology and surveillance. Nat Rev Immunol 21, 221\u2013232.","journal-title":"Nat Rev Immunol"},{"key":"2648_CR110","doi-asserted-by":"publisher","first-page":"e31311","DOI":"10.7554\/eLife.31311","volume":"6","author":"IA Roundtree","year":"2017","unstructured":"Roundtree, I.A., Luo, G.Z., Zhang, Z., Wang, X., Zhou, T., Cui, Y., Sha, J., Huang, X., Guerrero, L., Xie, P., et al. (2017). YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs. eLife 6, e31311.","journal-title":"eLife"},{"key":"2648_CR111","doi-asserted-by":"publisher","first-page":"13310","DOI":"10.1021\/acsomega.1c01289","volume":"6","author":"S Selberg","year":"2021","unstructured":"Selberg, S., Seli, N., Kankuri, E., and Karelson, M. (2021). Rational design of novel anticancer small-molecule RNA m6A demethylase ALKBH5 inhibitors. ACS Omega 6, 13310\u201313320.","journal-title":"ACS Omega"},{"key":"2648_CR112","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1016\/j.celrep.2017.11.092","volume":"21","author":"H Shima","year":"2017","unstructured":"Shima, H., Matsumoto, M., Ishigami, Y., Ebina, M., Muto, A., Sato, Y., Kumagai, S., Ochiai, K., Suzuki, T., and Igarashi, K. (2017). S-adenosylmethionine synthesis is regulated by selective N6-adenosine methylation and mRNA degradation involving METTL16 and YTHDC1. Cell Rep 21, 3354\u20133363.","journal-title":"Cell Rep"},{"key":"2648_CR113","doi-asserted-by":"publisher","first-page":"e0159072","DOI":"10.1371\/journal.pone.0159072","volume":"11","author":"B Singh","year":"2016","unstructured":"Singh, B., Kinne, H.E., Milligan, R.D., Washburn, L.J., Olsen, M., Lucci, A., and Tan, M. (2016). Important role of fto in the survival of rare panresistant triple-negative inflammatory breast cancer cells facing a severe metabolic challenge. PLoS ONE 11, e0159072.","journal-title":"PLoS ONE"},{"key":"2648_CR114","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1084\/jem.192.5.755","volume":"192","author":"MJ Smyth","year":"2000","unstructured":"Smyth, M.J., Thia, K.Y.T., Street, S.E.A., MacGregor, D., Godfrey, D.I., and Trapani, J. A. (2000). Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J Exp Med 192, 755\u2013760.","journal-title":"J Exp Med"},{"key":"2648_CR115","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1038\/s41467-021-25803-0","volume":"12","author":"H Song","year":"2021","unstructured":"Song, H., Song, J., Cheng, M., Zheng, M., Wang, T., Tian, S., Flavell, R.A., Zhu, S., Li, H.B., Ding, C., et al. (2021). METTL3-mediated m6A RNA methylation promotes the anti-tumour immunity of natural killer cells. Nat Commun 12, 5522.","journal-title":"Nat Commun"},{"key":"2648_CR116","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","volume":"172","author":"R Su","year":"2018","unstructured":"Su, R., Dong, L., Li, C., Nachtergaele, S., Wunderlich, M., Qing, Y., Deng, X., Wang, Y., Weng, X., Hu, C., et al. (2018). R-2HG exhibits anti-tumor activity by targeting FTO\/m6A\/MYC\/CEBPA signaling. Cell 172, 90\u2013105.e23.","journal-title":"Cell"},{"key":"2648_CR117","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","volume":"38","author":"R Su","year":"2020","unstructured":"Su, R., Dong, L., Li, Y., Gao, M., Han, L., Wunderlich, M., Deng, X., Li, H., Huang, Y., Gao, L., et al. (2020). Targeting FTO suppresses cancer stem cell maintenance and immune evasion. Cancer Cell 38, 79\u201396.e11.","journal-title":"Cancer Cell"},{"key":"2648_CR118","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41586-021-04057-2","volume":"599","author":"X Sun","year":"2021","unstructured":"Sun, X., Wu, B., Chiang, H.C., Deng, H., Zhang, X., Xiong, W., Liu, J., Rozeboom, A. M., Harris, B.T., Blommaert, E., et al. (2021). Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion. Nature 599, 673\u2013678.","journal-title":"Nature"},{"key":"2648_CR119","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/cr.2018.7","volume":"28","author":"J Tong","year":"2018","unstructured":"Tong, J., Cao, G., Zhang, T., Sefik, E., Amezcua Vesely, M.C., Broughton, J.P., Zhu, S., Li, H., Li, B., Chen, L., et al. (2018). m6A mRNA methylation sustains Treg suppressive functions. Cell Res 28, 253\u2013256.","journal-title":"Cell Res"},{"key":"2648_CR120","doi-asserted-by":"publisher","first-page":"eabd4742","DOI":"10.1126\/sciadv.abd4742","volume":"7","author":"J Tong","year":"2021","unstructured":"Tong, J., Wang, X., Liu, Y., Ren, X., Wang, A., Chen, Z., Yao, J., Mao, K., Liu, T., Meng, F.L., et al. (2021). Pooled CRISPR screening identifies m6A as a positive regulator of macrophage activation. Sci Adv 7, eabd4742.","journal-title":"Sci Adv"},{"key":"2648_CR121","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.1038\/s41467-018-07716-7","volume":"9","author":"L Tordesillas","year":"2018","unstructured":"Tordesillas, L., Lozano-Ojalvo, D., Dunkin, D., Mondoulet, L., Agudo, J., Merad, M., Sampson, H.A., and Berin, M.C. (2018). PDL2+ CD11b+ dermal dendritic cells capture topical antigen through hair follicles to prime LAP+ Tregs. Nat Commun 9, 5238.","journal-title":"Nat Commun"},{"key":"2648_CR122","doi-asserted-by":"publisher","first-page":"7719","DOI":"10.1093\/nar\/gkz619","volume":"47","author":"N van Tran","year":"2019","unstructured":"van Tran, N., Ernst, F.G.M., Hawley, B.R., Zorbas, C., Ulryck, N., Hackert, P., Bohnsack, K.E., Bohnsack, M.T., Jaffrey, S.R., Graille, M., et al. (2019). The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112. Nucleic Acids Res 47, 7719\u20137733.","journal-title":"Nucleic Acids Res"},{"key":"2648_CR123","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev-immunol-041015-055605","volume":"34","author":"CG Vinuesa","year":"2016","unstructured":"Vinuesa, C.G., Linterman, M.A., Yu, D., and MacLennan, I.C.M. (2016). Follicular helper T cells. Annu Rev Immunol 34, 335\u2013368.","journal-title":"Annu Rev Immunol"},{"key":"2648_CR124","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12943-021-01447-y","volume":"21","author":"W Wan","year":"2022","unstructured":"Wan, W., Ao, X., Chen, Q., Yu, Y., Ao, L., Xing, W., Guo, W., Wu, X., Pu, C., Hu, X., et al. (2022). METTL3\/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer. Mol Cancer 21, 60.","journal-title":"Mol Cancer"},{"key":"2648_CR125","doi-asserted-by":"publisher","first-page":"8444","DOI":"10.18632\/aging.204980","volume":"15","author":"A Wang","year":"2023","unstructured":"Wang, A., Sun, Y., Wang, X., Yan, Z., Wang, D., Zeng, L., and Lu, Q. (2023a). m6A methyltransferase METTL16 mediates immune evasion of colorectal cancer cells via epigenetically regulating PD-L1 expression. Aging 15, 8444\u20138457.","journal-title":"Aging"},{"key":"2648_CR126","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.jid.2023.01.027","volume":"143","author":"G Wang","year":"2023","unstructured":"Wang, G., Zeng, D., Sweren, E., Miao, Y., Chen, R., Chen, J., Wang, J., Liao, W., Hu, Z., Kang, S., et al. (2023b). N6-methyladenosine RNA methylation correlates with immune microenvironment and immunotherapy response of melanoma. J Investig Dermatol 143, 1579\u20131590.e5.","journal-title":"J Investig Dermatol"},{"key":"2648_CR127","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1038\/s41467-019-09903-6","volume":"10","author":"H Wang","year":"2019","unstructured":"Wang, H., Hu, X., Huang, M., Liu, J., Gu, Y., Ma, L., Zhou, Q., and Cao, X. (2019). Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation. Nat Commun 10, 1898.","journal-title":"Nat Commun"},{"key":"2648_CR128","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.ccell.2023.04.019","volume":"41","author":"L Wang","year":"2023","unstructured":"Wang, L., Dou, X., Chen, S., Yu, X., Huang, X., Zhang, L., Chen, Y., Wang, J., Yang, K., Bugno, J., et al. (2023c). YTHDF2 inhibition potentiates radiotherapy antitumor efficacy. Cancer Cell 41, 1294\u20131308.e8.","journal-title":"Cancer Cell"},{"key":"2648_CR129","doi-asserted-by":"publisher","first-page":"e104514","DOI":"10.15252\/embj.2020104514","volume":"39","author":"L Wang","year":"2020","unstructured":"Wang, L., Hui, H., Agrawal, K., Kang, Y., Li, N., Tang, R., Yuan, J., and Rana, T.M. (2020a). m6A RNA methyltransferases METTL3\/14 regulate immune responses to anti-PD-1 therapy. EMBO J 39, e104514.","journal-title":"EMBO J"},{"key":"2648_CR130","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.jhep.2023.06.021","volume":"79","author":"L Wang","year":"2023","unstructured":"Wang, L., Zhu, L., Liang, C., Huang, X., Liu, Z., Huo, J., Zhang, Y., Zhang, Y., Chen, L., Xu, H., et al. (2023d). Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis. J Hepatol 79, 1185\u20131200.","journal-title":"J Hepatol"},{"key":"2648_CR131","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.molcel.2016.05.041","volume":"63","author":"P Wang","year":"2016","unstructured":"Wang, P., Doxtader, K.A., and Nam, Y. (2016a). Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases. Mol Cell 63, 306\u2013317.","journal-title":"Mol Cell"},{"key":"2648_CR132","doi-asserted-by":"publisher","first-page":"110879","DOI":"10.1016\/j.intimp.2023.110879","volume":"124","author":"R Wang","year":"2023","unstructured":"Wang, R., Ye, H., Yang, B., Ao, M., Yu, X., Wu, Y., Xi, M., and Hou, M. (2023e). m6A-modified circNFIX promotes ovarian cancer progression and immune escape via activating IL-6R\/JAK1\/STAT3 signaling by sponging miR-647. Int Immunopharmacol 124, 110879.","journal-title":"Int Immunopharmacol"},{"key":"2648_CR133","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nature18298","volume":"534","author":"X Wang","year":"2016","unstructured":"Wang, X., Feng, J., Xue, Y., Guan, Z., Zhang, D., Liu, Z., Gong, Z., Wang, Q., Huang, J., Tang, C., et al. (2016b). Structural basis of N6-adenosine methylation by the METTL3\u2013METTL14 complex. Nature 534, 575\u2013578.","journal-title":"Nature"},{"key":"2648_CR134","doi-asserted-by":"publisher","first-page":"2100209","DOI":"10.1002\/advs.202100209","volume":"8","author":"X Wang","year":"2021","unstructured":"Wang, X., Ji, Y., Feng, P., Liu, R., Li, G., Zheng, J., Xue, Y., Wei, Y., Ji, C., Chen, D., et al. (2021). The m6A reader IGF2BP2 regulates macrophage phenotypic activation and inflammatory diseases by stabilizing TSC1 and PPAR \u03b3. Adv Sci 8, 2100209.","journal-title":"Adv Sci"},{"key":"2648_CR135","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","volume":"161","author":"X Wang","year":"2015","unstructured":"Wang, X., Zhao, B.S., Roundtree, I.A., Lu, Z., Han, D., Ma, H., Weng, X., Chen, K., Shi, H., and He, C. (2015). N6-methyladenosine modulates messenger RNA translation efficiency. Cell 161, 1388\u20131399.","journal-title":"Cell"},{"key":"2648_CR136","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s10495-023-01885-7","volume":"29","author":"Y Wang","year":"2024","unstructured":"Wang, Y., Jin, P., and Wang, X. (2024). N6-methyladenosine regulator YTHDF1 represses the CD8 + T cell-mediated antitumor immunity and ferroptosis in prostate cancer via m6A\/PD-L1 manner. Apoptosis 29, 142\u2013153.","journal-title":"Apoptosis"},{"key":"2648_CR137","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/s41467-020-15488-2","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang, Y., Gao, M., Zhu, F., Li, X., Yang, Y., Yan, Q., Jia, L., Xie, L., and Chen, Z. (2020b). METTL3 is essential for postnatal development of brown adipose tissue and energy expenditure in mice. Nat Commun 11, 1648.","journal-title":"Nat Commun"},{"key":"2648_CR138","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1126\/science.abe9582","volume":"376","author":"J Wei","year":"2022","unstructured":"Wei, J., Yu, X., Yang, L., Liu, X., Gao, B., Huang, B., Dou, X., Liu, J., Zou, Z., Cui, X.L., et al. (2022). FTO mediates LINE1 m6A demethylation and chromatin regulation in mESCs and mouse development. Science 376, 968\u2013973.","journal-title":"Science"},{"key":"2648_CR139","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.molcel.2017.09.021","volume":"68","author":"MN Wojtas","year":"2017","unstructured":"Wojtas, M.N., Pandey, R.R., Mendel, M., Homolka, D., Sachidanandam, R., and Pillai, R.S. (2017). Regulation of m6A transcripts by the 3\u2032\u21925\u2032 RNA helicase YTHDC2 is essential for a successful meiotic program in the mammalian germline. Mol Cell 68, 374\u2013387.e12.","journal-title":"Mol Cell"},{"key":"2648_CR140","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nature21671","volume":"543","author":"Y Xiang","year":"2017","unstructured":"Xiang, Y., Laurent, B., Hsu, C.H., Nachtergaele, S., Lu, Z., Sheng, W., Xu, C., Chen, H., Ouyang, J., Wang, S., et al. (2017). RNA m6A methylation regulates the ultraviolet-induced DNA damage response. Nature 543, 573\u2013576.","journal-title":"Nature"},{"key":"2648_CR141","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jpha.2023.04.009","volume":"13","author":"H Xiao","year":"2023","unstructured":"Xiao, H., Zhao, R., Meng, W., and Liao, Y. (2023a). Effects and translatomics characteristics of a small-molecule inhibitor of METTL3 against non-small cell lung cancer. J Pharm Anal 13, 625\u2013639.","journal-title":"J Pharm Anal"},{"key":"2648_CR142","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1158\/0008-5472.CAN-20-0132","volume":"80","author":"L Xiao","year":"2020","unstructured":"Xiao, L., Li, X., Mu, Z., Zhou, J., Zhou, P., Xie, C., and Jiang, S. (2020). FTO inhibition enhances the antitumor effect of temozolomide by targeting MYC-miR-155\/23a cluster-MXI1 feedback circuit in glioma. Cancer Res 80, 3945\u20133958.","journal-title":"Cancer Res"},{"key":"2648_CR143","doi-asserted-by":"publisher","first-page":"216075","DOI":"10.1016\/j.canlet.2023.216075","volume":"557","author":"P Xiao","year":"2023","unstructured":"Xiao, P., Meng, Q., Liu, Q., Lang, Q., Yin, Z., Li, G., Li, Z., Xu, Y., Yu, Z., Geng, Q., et al. (2023b). IGF2BP1-mediated N6-methyladenosine modification promotes intrahepatic cholangiocarcinoma progression. Cancer Lett 557, 216075.","journal-title":"Cancer Lett"},{"key":"2648_CR144","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.molcel.2016.01.012","volume":"61","author":"W Xiao","year":"2016","unstructured":"Xiao, W., Adhikari, S., Dahal, U., Chen, Y.S., Hao, Y.J., Sun, B.F., Sun, H.Y., Li, A., Ping, X.L., Lai, W.Y., et al. (2016). Nuclear m6A reader YTHDC1 regulates mRNA splicing. Mol Cell 61, 507\u2013519.","journal-title":"Mol Cell"},{"key":"2648_CR145","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bioactmat.2022.07.027","volume":"21","author":"Z Xiao","year":"2023","unstructured":"Xiao, Z., Li, T., Zheng, X., Lin, L., Wang, X., Li, B., Huang, J., Wang, Y., Shuai, X., and Zhu, K. (2023c). Nanodrug enhances post-ablation immunotherapy of hepatocellular carcinoma via promoting dendritic cell maturation and antigen presentation. Bioactive Mater 21, 57\u201368.","journal-title":"Bioactive Mater"},{"key":"2648_CR146","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.apsb.2021.08.028","volume":"12","author":"G Xie","year":"2022","unstructured":"Xie, G., Wu, X.N., Ling, Y., Rui, Y., Wu, D., Zhou, J., Li, J., Lin, S., Peng, Q., Li, Z., et al. (2022). A novel inhibitor of N6-methyladenosine demethylase FTO induces mRNA methylation and shows anti-cancer activities. Acta Pharm Sin B 12, 853\u2013866.","journal-title":"Acta Pharm Sin B"},{"key":"2648_CR147","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","volume":"82","author":"J Xiong","year":"2022","unstructured":"Xiong, J., He, J., Zhu, J., Pan, J., Liao, W., Ye, H., Wang, H., Song, Y., Du, Y., Cui, B., et al. (2022). Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol Cell 82, 1660\u20131677.e10.","journal-title":"Mol Cell"},{"key":"2648_CR148","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1007\/s11427-022-2295-0","volume":"66","author":"QP Xiong","year":"2023","unstructured":"Xiong, Q.P., Li, J., Li, H., Huang, Z.X., Dong, H., Wang, E.D., and Liu, R.J. (2023). Human TRMT1 catalyzes m2G or m22G formation on tRNAs in a substrate-dependent manner. Sci China Life Sci 66, 2295\u20132309.","journal-title":"Sci China Life Sci"},{"key":"2648_CR149","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/cac2.12443","volume":"43","author":"P Xu","year":"2023","unstructured":"Xu, P., Yang, J., Chen, Z., Zhang, X., Xia, Y., Wang, S., Wang, W., and Xu, Z. (2023). N6-methyladenosine modification of CENPF mRNA facilitates gastric cancer metastasis via regulating FAK nuclear export. Cancer Commun 43, 685\u2013705.","journal-title":"Cancer Commun"},{"key":"2648_CR150","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1038\/s41388-022-02185-1","volume":"41","author":"QC Xu","year":"2022","unstructured":"Xu, Q.C., Tien, Y.C., Shi, Y.H., Chen, S., Zhu, Y.Q., Huang, X.T., Huang, C.S., Zhao, W., and Yin, X.Y. (2022). METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m6A-YTHDF2-dependent manner. Oncogene 41, 1622\u20131633.","journal-title":"Oncogene"},{"key":"2648_CR151","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-022-00601-9","volume":"19","author":"H Yamaguchi","year":"2022","unstructured":"Yamaguchi, H., Hsu, J.M., Yang, W.H., and Hung, M.C. (2022). Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics. Nat Rev Clin Oncol 19, 287\u2013305.","journal-title":"Nat Rev Clin Oncol"},{"key":"2648_CR152","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/s41422-018-0097-4","volume":"28","author":"F Yan","year":"2018","unstructured":"Yan, F., Al-Kali, A., Zhang, Z., Liu, J., Pang, J., Zhao, N., He, C., Litzow, M.R., and Liu, S. (2018). A dynamic N6-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors. Cell Res 28, 1062\u20131076.","journal-title":"Cell Res"},{"key":"2648_CR153","doi-asserted-by":"publisher","first-page":"7957","DOI":"10.3390\/ijms24097957","volume":"24","author":"Q Yang","year":"2023","unstructured":"Yang, Q., and Al-Hendy, A. (2023). The functional role and regulatory mechanism of FTO m6A RNA demethylase in human uterine leiomyosarcoma. Int J Mol Sci 24, 7957.","journal-title":"Int J Mol Sci"},{"key":"2648_CR154","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1038\/s41467-019-10669-0","volume":"10","author":"S Yang","year":"2019","unstructured":"Yang, S., Wei, J., Cui, Y.H., Park, G., Shah, P., Deng, Y., Aplin, A.E., Lu, Z., Hwang, S., He, C., et al. (2019). m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade. Nat Commun 10, 2782.","journal-title":"Nat Commun"},{"key":"2648_CR155","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40104-022-00677-4","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang, Y., Han, W., Zhang, A., Zhao, M., Cong, W., Jia, Y., Wang, D., and Zhao, R. (2022). Chronic corticosterone disrupts the circadian rhythm of CRH expression and m6A RNA methylation in the chicken hypothalamus. J anim Sci Biotechnol 13, 29.","journal-title":"J anim Sci Biotechnol"},{"key":"2648_CR156","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","volume":"593","author":"E Yankova","year":"2021","unstructured":"Yankova, E., Blackaby, W., Albertella, M., Rak, J., De Braekeleer, E., Tsagkogeorga, G., Pilka, E.S., Aspris, D., Leggate, D., Hendrick, A.G., et al. (2021). Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature 593, 597\u2013601.","journal-title":"Nature"},{"key":"2648_CR157","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/s41467-021-21594-6","volume":"12","author":"Y Yao","year":"2021","unstructured":"Yao, Y., Yang, Y., Guo, W., Xu, L., You, M., Zhang, Y.C., Sun, Z., Cui, X., Yu, G., Qi, Z., et al. (2021). METTL3-dependent m6A modification programs T follicular helper cell differentiation. Nat Commun 12, 1333.","journal-title":"Nat Commun"},{"key":"2648_CR158","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1038\/s12276-023-01059-0","volume":"55","author":"G Ye","year":"2023","unstructured":"Ye, G., Li, J., Yu, W., Xie, Z., Zheng, G., Liu, W., Wang, S., Cao, Q., Lin, J., Su, Z., et al. (2023). ALKBH5 facilitates CYP1B1 mRNA degradation via m6A demethylation to alleviate MSC senescence and osteoarthritis progression. Exp Mol Med 55, 1743\u20131756.","journal-title":"Exp Mol Med"},{"key":"2648_CR159","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41418-021-00888-8","volume":"30","author":"H Yin","year":"2023","unstructured":"Yin, H., Chen, L., Piao, S., Wang, Y., Li, Z., Lin, Y., Tang, X., Zhang, H., Zhang, H., and Wang, X. (2023). M6A RNA methylation-mediated RMRP stability renders proliferation and progression of non-small cell lung cancer through regulating TGFBR1\/SMAD2\/SMAD3 pathway. Cell Death Differ 30, 605\u2013617.","journal-title":"Cell Death Differ"},{"key":"2648_CR160","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/s41467-021-21514-8","volume":"12","author":"H Yin","year":"2021","unstructured":"Yin, H., Zhang, X., Yang, P., Zhang, X., Peng, Y., Li, D., Yu, Y., Wu, Y., Wang, Y., Zhang, J., et al. (2021). RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming. Nat Commun 12, 1394.","journal-title":"Nat Commun"},{"key":"2648_CR161","doi-asserted-by":"publisher","first-page":"e2204910","DOI":"10.1002\/adma.202204910","volume":"35","author":"Q You","year":"2023","unstructured":"You, Q., Wang, F., Du, R., Pi, J., Wang, H., Huo, Y., Liu, J., Wang, C., Yu, J., Yang, Y., et al. (2023). m6A reader YTHDF1-targeting engineered small extracellular vesicles for gastric cancer therapy via epigenetic and immune regulation. Adv Mater 35, e2204910.","journal-title":"Adv Mater"},{"key":"2648_CR162","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.7150\/ijbs.70149","volume":"18","author":"Y You","year":"2022","unstructured":"You, Y., Wen, D., Zeng, L., Lu, J., Xiao, X., Chen, Y., Song, H., and Liu, Z. (2022). ALKBH5\/MAP3K8 axis regulates PD-L1+ macrophage infiltration and promotes hepatocellular carcinoma progression. Int J Biol Sci 18, 5001\u20135018.","journal-title":"Int J Biol Sci"},{"key":"2648_CR163","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.7150\/ijbs.70674","volume":"18","author":"R Yu","year":"2022","unstructured":"Yu, R., Wei, Y., He, C., Zhou, P., Yang, H., Deng, C., Liu, R., Wu, P., Gao, Q., and Cao, C. (2022). Integrative analyses of m6A regulators identify that METTL3 is associated with HPV status and immunosuppressive microenvironment in HPV-related cancers. Int J Biol Sci 18, 3874\u20133887.","journal-title":"Int J Biol Sci"},{"key":"2648_CR164","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","volume":"20","author":"S Zaccara","year":"2019","unstructured":"Zaccara, S., Ries, R.J., and Jaffrey, S.R. (2019). Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol 20, 608\u2013624.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2648_CR165","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1053\/j.gastro.2023.04.032","volume":"165","author":"J Zhai","year":"2023","unstructured":"Zhai, J., Chen, H., Wong, C.C., Peng, Y., Gou, H., Zhang, J., Pan, Y., Chen, D., Lin, Y., Wang, S., et al. (2023). ALKBH5 drives immune suppression via targeting AXIN2 to promote colorectal cancer and is a target for boosting immunotherapy. Gastroenterology 165, 445\u2013462.","journal-title":"Gastroenterology"},{"key":"2648_CR166","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40364-023-00479-4","volume":"11","author":"L Zhan","year":"2023","unstructured":"Zhan, L., Zhang, J., Zhang, J.H., Liu, X.J., Guo, B., Chen, J.H., Tang, Z.H., Wang, W.Y., Wang, Q.Y., Wei, B., et al. (2023). METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer. Biomark Res 11, 43.","journal-title":"Biomark Res"},{"key":"2648_CR167","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12943-020-01170-0","volume":"19","author":"B Zhang","year":"2020","unstructured":"Zhang, B., Wu, Q., Li, B., Wang, D., Wang, L., and Zhou, Y.L. (2020a). m6A regulatormediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer. Mol Cancer 19, 53.","journal-title":"Mol Cancer"},{"key":"2648_CR168","doi-asserted-by":"publisher","first-page":"216182","DOI":"10.1016\/j.canlet.2023.216182","volume":"562","author":"C Zhang","year":"2023","unstructured":"Zhang, C., Zhang, C., and Wang, H. (2023a). Immune-checkpoint inhibitor resistance in cancer treatment: Current progress and future directions. Cancer Lett 562, 216182.","journal-title":"Cancer Lett"},{"key":"2648_CR169","doi-asserted-by":"publisher","first-page":"e113126","DOI":"10.15252\/embj.2022113126","volume":"42","author":"L Zhang","year":"2023","unstructured":"Zhang, L., Dou, X., Zheng, Z., Ye, C., Lu, T.X., Liang, H.L., Wang, L., Weichselbaum, R.R., and He, C. (2023b). YTHDF2\/m6A\/NF-\u03baB axis controls anti-tumor immunity by regulating intratumoral Tregs. EMBO J 42, e113126.","journal-title":"EMBO J"},{"key":"2648_CR170","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1158\/0008-5472.CAN-22-2485","volume":"83","author":"L Zhang","year":"2023","unstructured":"Zhang, L., Li, Y., Zhou, L., Zhou, H., Ye, L., Ou, T., Hong, H., Zheng, S., Zhou, Z., Wu, K., et al. (2023c). The m6A reader YTHDF2 promotes bladder cancer progression by suppressing RIG-I\u2013mediated immune response. Cancer Res 83, 1834\u20131850.","journal-title":"Cancer Res"},{"key":"2648_CR171","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s12276-022-00735-x","volume":"54","author":"N Zhang","year":"2022","unstructured":"Zhang, N., Shen, Y., Li, H., Chen, Y., Zhang, P., Lou, S., and Deng, J. (2022). The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability. Exp Mol Med 54, 194\u2013205.","journal-title":"Exp Mol Med"},{"key":"2648_CR172","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/s41588-020-0644-z","volume":"52","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z., Luo, K., Zou, Z., Qiu, M., Tian, J., Sieh, L., Shi, H., Zou, Y., Wang, G., Morrison, J., et al. (2020b). Genetic analyses support the contribution of mRNA N6-methyladenosine (m6A) modification to human disease heritability. Nat Genet 52, 939\u2013949.","journal-title":"Nat Genet"},{"key":"2648_CR173","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1007\/s13238-020-00733-7","volume":"11","author":"LY Zhao","year":"2020","unstructured":"Zhao, L.Y., Song, J., Liu, Y., Song, C.X., and Yi, C. (2020). Mapping the epigenetic modifications of DNA and RNA. Protein Cell 11, 792\u2013808.","journal-title":"Protein Cell"},{"key":"2648_CR174","doi-asserted-by":"publisher","first-page":"e2205091","DOI":"10.1002\/advs.202205091","volume":"9","author":"Y Zhao","year":"2022","unstructured":"Zhao, Y., Huang, S., Tan, X., Long, L., He, Q., Liang, X., Bai, J., Li, Q., Lin, J., Li, Y., et al. (2022). N6-methyladenosine-modified CBX1 regulates nasopharyngeal carcinoma progression through heterochromatin formation and STAT1 activation. Adv Sci 9, e2205091.","journal-title":"Adv Sci"},{"key":"2648_CR175","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1021\/cn500042t","volume":"5","author":"G Zheng","year":"2014","unstructured":"Zheng, G., Cox, T., Tribbey, L., Wang, G.Z., Iacoban, P., Booher, M.E., Gabriel, G.J., Zhou, L., Bae, N., Rowles, J., et al. (2014). Synthesis of a FTO inhibitor with anticonvulsant activity. ACS Chem Neurosci 5, 658\u2013665.","journal-title":"ACS Chem Neurosci"},{"key":"2648_CR176","doi-asserted-by":"publisher","first-page":"845193","DOI":"10.3389\/fimmu.2022.845193","volume":"13","author":"H Zheng","year":"2022","unstructured":"Zheng, H., Zheng, W., Wang, Z., Tao, Y., Huang, Z., Yang, L., Ouyang, L., Duan, Z., Zhang, Y., Chen, B., et al. (2022). Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell-mediated antitumor activity. Front Immunol 13, 845193.","journal-title":"Front Immunol"},{"key":"2648_CR177","doi-asserted-by":"publisher","first-page":"107656","DOI":"10.1016\/j.biotechadv.2020.107656","volume":"45","author":"H Zheng","year":"2020","unstructured":"Zheng, H., Zhang, X., and Sui, N. (2020). Advances in the profiling of N6-methyladenosine (m6A) modifications. Biotechnol Adv 45, 107656.","journal-title":"Biotechnol Adv"},{"key":"2648_CR178","doi-asserted-by":"publisher","first-page":"e001646","DOI":"10.1136\/jitc-2020-001646","volume":"9","author":"J Zhong","year":"2021","unstructured":"Zhong, J., Liu, Z., Cai, C., Duan, X., Deng, T., and Zeng, G. (2021). m6A modification patterns and tumor immune landscape in clear cell renal carcinoma. J Immunother Cancer 9, e001646.","journal-title":"J Immunother Cancer"},{"key":"2648_CR179","doi-asserted-by":"publisher","first-page":"104268","DOI":"10.1016\/j.ebiom.2022.104268","volume":"84","author":"B Zhou","year":"2022","unstructured":"Zhou, B., Bie, F., Zang, R., Zhang, M., Song, P., Liu, L., Peng, Y., Bai, G., Zhao, J., and Gao, S. (2022). RNA modification writer expression profiles predict clinical outcomes and guide neoadjuvant immunotherapy in non-small cell lung cancer. eBioMedicine 84, 104268.","journal-title":"eBioMedicine"},{"key":"2648_CR180","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nature15377","volume":"526","author":"J Zhou","year":"2015","unstructured":"Zhou, J., Wan, J., Gao, X., Zhang, X., Jaffrey, S.R., and Qian, S.B. (2015). Dynamic m6A mRNA methylation directs translational control of heat shock response. Nature 526, 591\u2013594.","journal-title":"Nature"},{"key":"2648_CR181","doi-asserted-by":"publisher","first-page":"eabg0470","DOI":"10.1126\/sciadv.abg0470","volume":"7","author":"J Zhou","year":"2021","unstructured":"Zhou, J., Zhang, X., Hu, J., Qu, R., Yu, Z., Xu, H., Chen, H., Yan, L., Ding, C., Zou, Q., et al. (2021a). m6A demethylase ALKBH5 controls CD4+ T cell pathogenicity and promotes autoimmunity. Sci Adv 7, eabg0470.","journal-title":"Sci Adv"},{"key":"2648_CR182","doi-asserted-by":"publisher","first-page":"103271","DOI":"10.1016\/j.ebiom.2021.103271","volume":"65","author":"Z Zhou","year":"2021","unstructured":"Zhou, Z., Zhang, J., Xu, C., Yang, J., Zhang, Y., Liu, M., Shi, X., Li, X., Zhan, H., Chen, W., et al. (2021b). An integrated model of N6-methyladenosine regulators to predict tumor aggressiveness and immune evasion in pancreatic cancer. EBioMedicine 65, 103271.","journal-title":"EBioMedicine"},{"key":"2648_CR183","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejmech.2017.12.026","volume":"144","author":"G Zhu","year":"2018","unstructured":"Zhu, G., Xu, Y., Cen, X., Nandakumar, K.S., Liu, S., and Cheng, K. (2018). Targeting pattern-recognition receptors to discover new small molecule immune modulators. Eur J Med Chem 144, 82\u201392.","journal-title":"Eur J Med Chem"},{"key":"2648_CR184","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1084\/jem.20190337","volume":"216","author":"Y Zhu","year":"2019","unstructured":"Zhu, Y., Zhao, Y., Zou, L., Zhang, D., Aki, D., and Liu, Y.C. (2019). The E3 ligase VHL promotes follicular helper T cell differentiation via glycolytic-epigenetic control. J Exp Med 216, 1664\u20131681.","journal-title":"J Exp Med"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-024-2648-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11427-024-2648-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-024-2648-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T16:35:29Z","timestamp":1743870929000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11427-024-2648-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":184,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["2648"],"URL":"https:\/\/doi.org\/10.1007\/s11427-024-2648-0","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,6]]},"assertion":[{"value":"2 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author(s) declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance and ethics"}}]}}